ARTICLE | Clinical News
SNS-062: Preliminary Phase Ia data
September 19, 2016 7:00 AM UTC
Preliminary data from a double-blind, placebo-controlled, Belgian Phase Ia trial in 32 healthy volunteers showed that single doses of 50, 100, 200 and 300 mg oral SNS-062 led to no serious adverse eve...